• Search

Search in Site

Industry news and analysis across pharma and medical devices PharmaDeviceNews.com

  • Home
  • Pharma & Biotech
  • Medical Devices & Diagnostics
  • Features & Analysis
  • Privacy Policy
  • About PharmaDeviceNews
  • Editorial Policy
  • Disclaimer
  • Contact Us
Home»Posts tagged with»latanoprost

Can smaller eyedrops improve glaucoma outcomes? Nanodropper data make the case

By Pallavi Madhiraju on March 26, 2026   Medical Devices & Diagnostics  

Can smaller eyedrops improve glaucoma outcomes? Nanodropper data make the case

Nanodropper’s glaucoma study suggests microdrops may improve pressure control and reduce waste. Read what this could mean for eye care.

Recent Posts

  • Why HOPE Therapeutics’ first Zeta-guided TMS patients matter for psychiatry care
  • Does the FDA’s KOURAGE response restore confidence in CalciMedica’s CRAC platform?
  • Is CONNEQT Health building a scalable medical software platform or another funding cycle?
  • Can TScan’s TSC-101 Phase 1 data justify a pivotal leap as TCRX stock falls?
  • Could zervimesine become the first approved treatment for dementia with Lewy bodies psychosis?
  • Could Absci’s ABS-201 open a new biologic pathway for androgenetic alopecia treatment?
  • One Biosciences advances OneMap platform toward clinical-grade ADC biomarker use
  • Sigvotatug vedotin Phase 3 miss tests Pfizer’s case for integrin beta-6 targeted ADCs
  • Galmed buys Colospan as its FDA Breakthrough Device faces a pivotal clinical test
  • Can Definium turn a 50% stock surge into an FDA path for single-dose depression therapy?
  • Antengene, K2 Therapeutics deal signals fresh momentum for solid tumor TCEs
  • Why Insilico’s $2.5bn SK Biopharmaceuticals deal could reshape AI drug discovery
    • About PharmaDeviceNews
    • Contact Us
    • Disclaimer
    • Editorial Policy
    • Privacy Policy
© 2026, ↑ PharmaDeviceNews
Log in - Powered by WordPress - Gabfire Themes